PDB Short entry for 2FY5 HEADER TRANSFERASE 07-FEB-06 2FY5 TITLE STRUCTURES OF LIGAND BOUND HUMAN CHOLINE ACETYLTRANSFERASE PROVIDE TITLE 2 INSIGHT INTO REGULATION OF ACETYLCHOLINE SYNTHESIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHOLINE O-ACETYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 120-733; COMPND 5 SYNONYM: CHOACTASE, CHOLINE ACETYLASE, CHAT; COMPND 6 EC: 2.3.1.6; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CHAT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEXHTA KEYWDS TWO DOMAIN, ALPHA-BETA PROTEIN, TRANSFERASE, S-2-(OXOPROPYL)-COENZYME KEYWDS 2 A EXPDTA X-RAY DIFFRACTION AUTHOR A.R.KIM,R.J.RYLETT,B.H.SHILTON REVDAT 5 30-AUG-23 2FY5 1 REMARK REVDAT 4 20-OCT-21 2FY5 1 REMARK SEQADV REVDAT 3 18-OCT-17 2FY5 1 REMARK REVDAT 2 24-FEB-09 2FY5 1 VERSN REVDAT 1 12-DEC-06 2FY5 0 JRNL AUTH A.R.KIM,R.J.RYLETT,B.H.SHILTON JRNL TITL SUBSTRATE BINDING AND CATALYTIC MECHANISM OF HUMAN CHOLINE JRNL TITL 2 ACETYLTRANSFERASE. JRNL REF BIOCHEMISTRY V. 45 14621 2006 JRNL REFN ISSN 0006-2960 JRNL PMID 17144655 JRNL DOI 10.1021/BI061536L REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 20754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2077 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2326 REMARK 3 BIN R VALUE (WORKING SET) : 0.3430 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 247 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4514 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 52 REMARK 3 SOLVENT ATOMS : 104 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 11.84000 REMARK 3 B22 (A**2) : -11.87000 REMARK 3 B33 (A**2) : 0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.44 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 27.29 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : SOP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : SOP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2FY5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-MAR-06. REMARK 100 THE DEPOSITION ID IS D_1000036449. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRADED MULTILAYER (OSMIC) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21009 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.7 REMARK 200 DATA REDUNDANCY : 18.40 REMARK 200 R MERGE (I) : 0.13300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 16.20 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1Q6X REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 11-13% PEG 3350, 0.1M TRIS-HCL, REMARK 280 CRYSTAL SOAKED IN 20MM S-(2-OXOPROPYL)-COENZYME A, PH 8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.63500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.91500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.01500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.91500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.63500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.01500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 LYS A 4 REMARK 465 THR A 5 REMARK 465 PRO A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 GLU A 9 REMARK 465 GLU A 10 REMARK 465 ALA A 174 REMARK 465 GLN A 175 REMARK 465 ASN A 176 REMARK 465 SER A 177 REMARK 465 SER A 178 REMARK 465 ILE A 179 REMARK 465 THR A 346 REMARK 465 GLN A 347 REMARK 465 PRO A 348 REMARK 465 GLU A 349 REMARK 465 LEU A 350 REMARK 465 VAL A 351 REMARK 465 ARG A 352 REMARK 465 SER A 353 REMARK 465 PRO A 354 REMARK 465 MET A 355 REMARK 465 VAL A 356 REMARK 465 PRO A 608 REMARK 465 PRO A 609 REMARK 465 THR A 610 REMARK 465 GLU A 611 REMARK 465 SER A 612 REMARK 465 LYS A 613 REMARK 465 PRO A 614 REMARK 465 LEU A 615 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 85 -54.09 -129.38 REMARK 500 VAL A 94 -48.35 69.23 REMARK 500 SER A 96 -50.62 -138.32 REMARK 500 LEU A 145 92.34 78.68 REMARK 500 TYR A 156 44.69 -60.06 REMARK 500 ILE A 201 -108.68 -66.48 REMARK 500 ASN A 202 76.13 -101.43 REMARK 500 LEU A 206 148.98 -25.76 REMARK 500 ALA A 222 0.39 -67.62 REMARK 500 CYS A 268 -172.21 -171.45 REMARK 500 VAL A 278 -170.20 -52.71 REMARK 500 LEU A 280 49.80 -83.96 REMARK 500 LYS A 297 -82.16 -117.09 REMARK 500 ASN A 298 11.69 -143.81 REMARK 500 TRP A 303 80.91 -156.91 REMARK 500 ARG A 442 1.81 -58.59 REMARK 500 GLU A 446 14.43 57.98 REMARK 500 ARG A 448 -87.29 -106.02 REMARK 500 ALA A 501 -163.48 -77.58 REMARK 500 THR A 546 -162.31 -56.63 REMARK 500 LEU A 606 -98.96 -74.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SOP A 2000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FY2 RELATED DB: PDB REMARK 900 RELATED ID: 2FY3 RELATED DB: PDB REMARK 900 RELATED ID: 2FY4 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE ORIGINAL SEQUENCE SSRKLIRADSVSE (RESIDUES 464-476 REMARK 999 IN SWS ENTRY CLAT_HUMAN) WAS MUTATED TO THE SEQUENCE REMARK 999 PELVRSPMVP (RESIDUES 346-357 IN THE COORDINATES) IN REMARK 999 ORDER TO MAKE THE PROTEIN CRYSTALLIZE. THE OTHER REMARK 999 MUTATIONS MENTIONED IN SEQADV WERE MADE FOR THE SAME REMARK 999 PURPOSE. DBREF 2FY5 A 2 615 UNP P28329 CLAT_HUMAN 120 733 SEQADV 2FY5 ALA A 1 UNP P28329 CLONING ARTIFACT SEQADV 2FY5 ALA A 225 UNP P28329 GLU 343 ENGINEERED MUTATION SEQADV 2FY5 ALA A 226 UNP P28329 ASP 344 ENGINEERED MUTATION SEQADV 2FY5 ALA A 227 UNP P28329 GLU 345 ENGINEERED MUTATION SEQADV 2FY5 A UNP P28329 SER 464 SEE REMARK 999 SEQADV 2FY5 A UNP P28329 SER 465 SEE REMARK 999 SEQADV 2FY5 PRO A 348 UNP P28329 ARG 466 SEE REMARK 999 SEQADV 2FY5 GLU A 349 UNP P28329 LYS 467 SEE REMARK 999 SEQADV 2FY5 VAL A 351 UNP P28329 ILE 469 SEE REMARK 999 SEQADV 2FY5 SER A 353 UNP P28329 ALA 471 SEE REMARK 999 SEQADV 2FY5 PRO A 354 UNP P28329 ASP 472 SEE REMARK 999 SEQADV 2FY5 MET A 355 UNP P28329 SER 473 SEE REMARK 999 SEQADV 2FY5 A UNP P28329 SER 475 SEE REMARK 999 SEQADV 2FY5 PRO A 357 UNP P28329 GLU 476 SEE REMARK 999 SEQADV 2FY5 ALA A 518 UNP P28329 LYS 636 ENGINEERED MUTATION SEQADV 2FY5 ALA A 519 UNP P28329 GLU 637 ENGINEERED MUTATION SEQADV 2FY5 ALA A 582 UNP P28329 LYS 700 ENGINEERED MUTATION SEQADV 2FY5 ALA A 583 UNP P28329 GLU 701 ENGINEERED MUTATION SEQRES 1 A 612 ALA ALA ALA LYS THR PRO SER SER GLU GLU SER GLY LEU SEQRES 2 A 612 PRO LYS LEU PRO VAL PRO PRO LEU GLN GLN THR LEU ALA SEQRES 3 A 612 THR TYR LEU GLN CYS MET ARG HIS LEU VAL SER GLU GLU SEQRES 4 A 612 GLN PHE ARG LYS SER GLN ALA ILE VAL GLN GLN PHE GLY SEQRES 5 A 612 ALA PRO GLY GLY LEU GLY GLU THR LEU GLN GLN LYS LEU SEQRES 6 A 612 LEU GLU ARG GLN GLU LYS THR ALA ASN TRP VAL SER GLU SEQRES 7 A 612 TYR TRP LEU ASN ASP MET TYR LEU ASN ASN ARG LEU ALA SEQRES 8 A 612 LEU PRO VAL ASN SER SER PRO ALA VAL ILE PHE ALA ARG SEQRES 9 A 612 GLN HIS PHE PRO GLY THR ASP ASP GLN LEU ARG PHE ALA SEQRES 10 A 612 ALA SER LEU ILE SER GLY VAL LEU SER TYR LYS ALA LEU SEQRES 11 A 612 LEU ASP SER HIS SER ILE PRO THR ASP CYS ALA LYS GLY SEQRES 12 A 612 GLN LEU SER GLY GLN PRO LEU CYS MET LYS GLN TYR TYR SEQRES 13 A 612 GLY LEU PHE SER SER TYR ARG LEU PRO GLY HIS THR GLN SEQRES 14 A 612 ASP THR LEU VAL ALA GLN ASN SER SER ILE MET PRO GLU SEQRES 15 A 612 PRO GLU HIS VAL ILE VAL ALA CYS CYS ASN GLN PHE PHE SEQRES 16 A 612 VAL LEU ASP VAL VAL ILE ASN PHE ARG ARG LEU SER GLU SEQRES 17 A 612 GLY ASP LEU PHE THR GLN LEU ARG LYS ILE VAL LYS MET SEQRES 18 A 612 ALA SER ASN ALA ALA ALA ARG LEU PRO PRO ILE GLY LEU SEQRES 19 A 612 LEU THR SER ASP GLY ARG SER GLU TRP ALA GLU ALA ARG SEQRES 20 A 612 THR VAL LEU VAL LYS ASP SER THR ASN ARG ASP SER LEU SEQRES 21 A 612 ASP MET ILE GLU ARG CYS ILE CYS LEU VAL CYS LEU ASP SEQRES 22 A 612 ALA PRO GLY GLY VAL GLU LEU SER ASP THR HIS ARG ALA SEQRES 23 A 612 LEU GLN LEU LEU HIS GLY GLY GLY TYR SER LYS ASN GLY SEQRES 24 A 612 ALA ASN ARG TRP TYR ASP LYS SER LEU GLN PHE VAL VAL SEQRES 25 A 612 GLY ARG ASP GLY THR CYS GLY VAL VAL CYS GLU HIS SER SEQRES 26 A 612 PRO PHE ASP GLY ILE VAL LEU VAL GLN CYS THR GLU HIS SEQRES 27 A 612 LEU LEU LYS HIS MET THR GLN PRO GLU LEU VAL ARG SER SEQRES 28 A 612 PRO MET VAL PRO LEU PRO ALA PRO ARG ARG LEU ARG TRP SEQRES 29 A 612 LYS CYS SER PRO GLU ILE GLN GLY HIS LEU ALA SER SER SEQRES 30 A 612 ALA GLU LYS LEU GLN ARG ILE VAL LYS ASN LEU ASP PHE SEQRES 31 A 612 ILE VAL TYR LYS PHE ASP ASN TYR GLY LYS THR PHE ILE SEQRES 32 A 612 LYS LYS GLN LYS CYS SER PRO ASP ALA PHE ILE GLN VAL SEQRES 33 A 612 ALA LEU GLN LEU ALA PHE TYR ARG LEU HIS ARG ARG LEU SEQRES 34 A 612 VAL PRO THR TYR GLU SER ALA SER ILE ARG ARG PHE GLN SEQRES 35 A 612 GLU GLY ARG VAL ASP ASN ILE ARG SER ALA THR PRO GLU SEQRES 36 A 612 ALA LEU ALA PHE VAL ARG ALA VAL THR ASP HIS LYS ALA SEQRES 37 A 612 ALA VAL PRO ALA SER GLU LYS LEU LEU LEU LEU LYS ASP SEQRES 38 A 612 ALA ILE ARG ALA GLN THR ALA TYR THR VAL MET ALA ILE SEQRES 39 A 612 THR GLY MET ALA ILE ASP ASN HIS LEU LEU ALA LEU ARG SEQRES 40 A 612 GLU LEU ALA ARG ALA MET CYS ALA ALA LEU PRO GLU MET SEQRES 41 A 612 PHE MET ASP GLU THR TYR LEU MET SER ASN ARG PHE VAL SEQRES 42 A 612 LEU SER THR SER GLN VAL PRO THR THR THR GLU MET PHE SEQRES 43 A 612 CYS CYS TYR GLY PRO VAL VAL PRO ASN GLY TYR GLY ALA SEQRES 44 A 612 CYS TYR ASN PRO GLN PRO GLU THR ILE LEU PHE CYS ILE SEQRES 45 A 612 SER SER PHE HIS SER CYS ALA ALA THR SER SER SER LYS SEQRES 46 A 612 PHE ALA LYS ALA VAL GLU GLU SER LEU ILE ASP MET ARG SEQRES 47 A 612 ASP LEU CYS SER LEU LEU PRO PRO THR GLU SER LYS PRO SEQRES 48 A 612 LEU HET SOP A2000 52 HETNAM SOP [(2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-HYDROXY-3- HETNAM 2 SOP (PHOSPHONOOXY)TETRAHYDROFURAN-2-YL]METHYL (3R)-3- HETNAM 3 SOP HYDROXY-2,2-DIMETHYL-4-OXO-4-{[3-OXO-3-({2-[(2- HETNAM 4 SOP OXOPROPYL)THIO]ETHYL}AMINO)PROPYL]AMINO}BUTYL HETNAM 5 SOP DIHYDROGEN DIPHOSPHATE HETSYN SOP S-(2-OXOPROPYL)-COENZYME A FORMUL 2 SOP C24 H40 N7 O17 P3 S FORMUL 3 HOH *104(H2 O) HELIX 1 1 PRO A 20 ARG A 33 1 14 HELIX 2 2 HIS A 34 VAL A 36 5 3 HELIX 3 3 SER A 37 ALA A 53 1 17 HELIX 4 4 GLY A 56 THR A 72 1 17 HELIX 5 5 VAL A 76 TYR A 85 1 10 HELIX 6 6 ALA A 91 SER A 96 1 6 HELIX 7 7 GLY A 109 SER A 133 1 25 HELIX 8 8 GLN A 154 LEU A 158 5 5 HELIX 9 9 SER A 207 ALA A 222 1 16 HELIX 10 10 PRO A 231 ASP A 238 5 8 HELIX 11 11 GLY A 239 VAL A 251 1 13 HELIX 12 12 ASP A 253 ARG A 265 1 13 HELIX 13 13 SER A 281 HIS A 291 1 11 HELIX 14 14 ASP A 328 MET A 343 1 16 HELIX 15 15 SER A 370 ASN A 390 1 21 HELIX 16 16 GLY A 402 LYS A 408 1 7 HELIX 17 17 SER A 412 ARG A 430 1 19 HELIX 18 18 THR A 456 ASP A 468 1 13 HELIX 19 19 HIS A 469 ALA A 472 5 4 HELIX 20 20 PRO A 474 THR A 498 1 25 HELIX 21 21 ILE A 502 CYS A 517 1 16 HELIX 22 22 PRO A 521 ASP A 526 1 6 HELIX 23 23 ASP A 526 ASN A 533 1 8 HELIX 24 24 SER A 585 SER A 605 1 21 SHEET 1 A 8 ARG A 363 ARG A 364 0 SHEET 2 A 8 GLN A 193 VAL A 200 -1 N VAL A 196 O ARG A 363 SHEET 3 A 8 GLU A 184 CYS A 190 -1 N VAL A 186 O LEU A 197 SHEET 4 A 8 LEU A 269 CYS A 271 1 O VAL A 270 N ILE A 187 SHEET 5 A 8 LEU A 308 VAL A 312 1 O VAL A 312 N CYS A 271 SHEET 6 A 8 CYS A 318 CYS A 322 -1 O VAL A 321 N GLN A 309 SHEET 7 A 8 ALA A 99 ILE A 101 -1 N VAL A 100 O VAL A 320 SHEET 8 A 8 PHE A 549 CYS A 551 -1 O PHE A 549 N ILE A 101 SHEET 1 B 2 ARG A 163 LEU A 164 0 SHEET 2 B 2 THR A 171 LEU A 172 -1 O THR A 171 N LEU A 164 SHEET 1 C 6 LEU A 391 PHE A 398 0 SHEET 2 C 6 ILE A 571 PHE A 578 -1 O PHE A 573 N TYR A 396 SHEET 3 C 6 TYR A 560 PRO A 566 -1 N GLY A 561 O SER A 576 SHEET 4 C 6 LEU A 537 GLN A 541 1 N SER A 538 O ALA A 562 SHEET 5 C 6 THR A 435 SER A 440 1 N TYR A 436 O THR A 539 SHEET 6 C 6 VAL A 449 ASN A 451 -1 O ASP A 450 N ALA A 439 CISPEP 1 GLU A 182 PRO A 183 0 0.65 SITE 1 AC1 22 PRO A 98 GLY A 143 GLN A 144 HIS A 324 SITE 2 AC1 22 GLY A 329 ILE A 330 LYS A 403 LYS A 407 SITE 3 AC1 22 LYS A 410 CYS A 411 SER A 412 PRO A 413 SITE 4 AC1 22 ASP A 414 SER A 438 SER A 440 THR A 493 SITE 5 AC1 22 GLN A 541 VAL A 542 CYS A 550 HOH A 700 SITE 6 AC1 22 HOH A 734 HOH A 776 CRYST1 55.270 74.030 165.830 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018093 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013508 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006030 0.00000